Anti-inflammatory treatment is the pharmacological cornerstone of asthma management. However, for a long time, short-acting beta-agonists (SABAs) have been proposed as rescue medications in all treatment steps and as monotherapy for milder asthma. This was based on the unproven assumption that symptom relief requires only bronchodilation. Herein, we describe the evolution of the Inhaled corticosteroid (ICS) Containing resCUE (IC-CUE; ICQ) algorithm by tracing its origins and projecting it into the future.
The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management
Papi, A
Primo
;Alfano, F;Baraldi, FPenultimo
;
2022
Abstract
Anti-inflammatory treatment is the pharmacological cornerstone of asthma management. However, for a long time, short-acting beta-agonists (SABAs) have been proposed as rescue medications in all treatment steps and as monotherapy for milder asthma. This was based on the unproven assumption that symptom relief requires only bronchodilation. Herein, we describe the evolution of the Inhaled corticosteroid (ICS) Containing resCUE (IC-CUE; ICQ) algorithm by tracing its origins and projecting it into the future.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Allergy - 2021 - Papi - The ICQ asthma algorithm Inhaled corticosteroid Containing resCUE ICQ treatment for present and.pdf
solo gestori archivio
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
233.58 kB
Formato
Adobe PDF
|
233.58 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
